Kost B - Search Results

1

Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic: experience from an academic high-level endometriosis centre in Germany.

Keilmann L, Beyer S, Meister S, Jegen M, Buschmann C, Schröder L, Keckstein S, Jeschke U, Burges A, Mahner S, Trillsch F, Kost B, Kolben T. Keilmann L, et al. Among authors: kost b. Arch Gynecol Obstet. 2023 Jan;307(1):129-137. doi: 10.1007/s00404-022-06730-x. Epub 2022 Sep 7. Arch Gynecol Obstet. 2023. PMID: 36068363 Free PMC article.

2

HIV testing in pregnancy: are we testing enough?

Kost BP, Gingelmaier A, Kainer F, Friese K, Mylonas I. Kost BP, et al. Arch Gynecol Obstet. 2011 Aug;284(2):357-60. doi: 10.1007/s00404-010-1639-2. Epub 2010 Aug 18. Arch Gynecol Obstet. 2011. PMID: 20717687

3

The expression of thyroid hormone receptors (THR) is regulated by the progesterone receptor system in first trimester placental tissue and in BeWo cells in vitro.

Vattai A, Ziegelmüller B, Kost B, Kuhn C, Hofmann S, Bayer B, Anslinger K, Jeschke U, Ditsch N. Vattai A, et al. Among authors: kost b. Eur J Obstet Gynecol Reprod Biol. 2015 Dec;195:31-39. doi: 10.1016/j.ejogrb.2015.09.003. Epub 2015 Sep 30. Eur J Obstet Gynecol Reprod Biol. 2015. PMID: 26476797

4

Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients.

Rack B, Zombirt E, Trapp E, Jückstock J, Andergassen U, Neugebauer J, Kost B, Weissenbacher T, Jeschke U, Schindlbeck C, Janni W, Alunni-Fabbroni M. Rack B, et al. Among authors: kost b. Oncology. 2016;90(4):232-8. doi: 10.1159/000442986. Epub 2016 Mar 4. Oncology. 2016. PMID: 26937631

5

Immunohistochemical Evaluation of the Role of p53 Mutation in Cervical Cancer: Ser-20 p53-Mutant Correlates with Better Prognosis.

Freier CP, Stiasny A, Kuhn C, Mayr D, Alexiou C, Janko C, Wiest I, Jeschke U, Kost B. Freier CP, et al. Among authors: kost b. Anticancer Res. 2016 Jun;36(6):3131-7. Anticancer Res. 2016. PMID: 27272838

6

Immunohistochemical Evaluation of E6/E7 HPV Oncoproteins Staining in Cervical Cancer.

Stiasny A, Kuhn C, Mayr D, Alexiou C, Janko C, Wiest I, Jeschke U, Kost B. Stiasny A, et al. Among authors: kost b. Anticancer Res. 2016 Jun;36(6):3195-8. Anticancer Res. 2016. PMID: 27272848

7

The Effects of Petroselinum Crispum on Estrogen Receptor-positive Benign and Malignant Mammary Cells (MCF12A/MCF7).

Schröder L, Koch J, Mahner S, Kost BP, Hofmann S, Jeschke U, Haumann J, Schmedt J, Richter DU. Schröder L, et al. Anticancer Res. 2017 Jan;37(1):95-102. doi: 10.21873/anticanres.11294. Anticancer Res. 2017. PMID: 28011479

8

Histone H3 Acetyl K9 and Histone H3 Tri Methyl K4 as Prognostic Markers for Patients with Cervical Cancer.

Beyer S, Zhu J, Mayr D, Kuhn C, Schulze S, Hofmann S, Dannecker C, Jeschke U, Kost BP. Beyer S, et al. Int J Mol Sci. 2017 Feb 23;18(3):477. doi: 10.3390/ijms18030477. Int J Mol Sci. 2017. PMID: 28241481 Free PMC article.

9

The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients.

Heidegger H, Dietlmeier S, Ye Y, Kuhn C, Vattai A, Aberl C, Jeschke U, Mahner S, Kost B. Heidegger H, et al. Among authors: kost b. Int J Mol Sci. 2017 Jul 19;18(7):1571. doi: 10.3390/ijms18071571. Int J Mol Sci. 2017. PMID: 28753926 Free PMC article.

10

The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer.

Friese K, Kost B, Vattai A, Marmé F, Kuhn C, Mahner S, Dannecker C, Jeschke U, Heublein S. Friese K, et al. Among authors: kost b. J Cancer Res Clin Oncol. 2018 Jan;144(1):13-19. doi: 10.1007/s00432-017-2510-7. Epub 2017 Sep 18. J Cancer Res Clin Oncol. 2018. PMID: 28924735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page